Crossmark

Dose optimization in surgical prophylaxis: sub-inhibitory dosing of vancomycin increases rates of biofilm formation and the rates of surgical site infection

Crossref DOI link: https://doi.org/10.1038/s41598-023-30951-y

Published Online: 2023-03-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brothers, Kimberly M.

Parker, Dana M.

Taguchi, Masashi

Ma, Dongzhu

Mandell, Jonathan B.

Thurlow, Lance L.

Byrapogu, Venkata C.

Urish, Kenneth L.
Funding

Funding for this research was provided by:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS K08AR071494)

National Center for Advancing Translational Sciences (NCATS KL2TR0001856)
License Information

Text and Data Mining valid from 2023-03-21

Version of Record valid from 2023-03-21
More Information

Article History

Received: 4 December 2022

Accepted: 3 March 2023

First Online: 21 March 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below